World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
45
Citations
9661
World Ranking
6860
National Ranking
537

Dawn Langdon publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Dawn Langdon sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 158 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Dawn Langdon D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Dawn Langdon sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 45 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Dawn Langdon is affiliated with Royal Holloway University of London in the United Kingdom. Their research primarily focuses on the field of Medicine, with a particular emphasis on Multiple Sclerosis research and related disorders.

The areas of study most frequently addressed in Langdon's work include:

  • Pathology and Forensic Medicine
  • Psychiatry and Mental Health
  • Oncology
  • Neurology
  • Clinical Psychology

Langdon's research contributions focus mainly on topics such as:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and Related Diseases
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Autoimmune and Inflammatory Disorders Research
  • Fungal Plant Pathogen Control
  • Powdery Mildew Fungal Diseases
  • Cystic Fibrosis Research Advances

The researcher has authored or co-authored several recent papers, including:

  • "Identifying Progression in Multiple Sclerosis: New Perspectives," 2020, Annals of Neurology
  • "Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review," 2021, Journal of Neurology
  • "A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study," 2020, Multiple Sclerosis Journal
  • "A Systematic Review and Meta-Analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) International Validations," 2023, Journal of Clinical Medicine
  • "Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives," 2021, Patient Preference and Adherence

Langdon collaborates frequently with several co-authors, including:

  • Alessandra Solari
  • Carolyn Young
  • Nektaria Alexandri
  • Roger Mills
  • Bruno Brochet

Their work has been published in multiple scientific venues, with the highest number of publications appearing in:

  • Multiple Sclerosis and Related Disorders
  • Multiple Sclerosis Journal
  • Neurology and Therapy
  • Annals of Neurology
  • Frontiers in Neurology

Best Publications

  • Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

    Dawn Langdon;M P Amato;J Boringa;B Brochet

  • Minimal neuropsychological assessment of MS patients: a consensus approach.

    Ralph H.B. Benedict;Ralph H.B. Benedict;Jill S. Fischer;Cate J. Archibald;Peter Andrew Arnett

  • Cognition in multiple sclerosis.

    Dawn W Langdon

  • Brief International Cognitive Assessment for MS (BICAMS): international standards for validation

    Ralph H B Benedict;Maria Pia Amato;Jan Boringa;Bruno Brochet

  • Evidence-based measurement: which disability scale for neurologic rehabilitation?

    J. C. Hobart;D. L. Lamping;J. A. Freeman;D. W. Langdon

  • Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

    S. J. Camp;V. L. Stevenson;A. J. Thompson;D. H. Miller

  • The impact of inpatient rehabilitation on progressive multiple sclerosis

    J. A. Freeman;D. W. Langdon;J. C. Hobart;A. J. Thompson

  • Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial

    D.S. Goodin;A.T. Reder;G.C. Ebers;G. Cutter

  • Executive function and language in deaf children.

    Berta Figueras;Lindsey Edwards;Dawn Langdon

  • Treatment of cognitive impairment in multiple sclerosis: position paper

    Maria Pia Amato;Dawn Langdon;Xavier Montalban;Ralph H. B. Benedict

  • Inpatient rehabilitation in multiple sclerosis Do the benefits carry over into the community

    J.A. Freeman;D.W. Langdon;J.C. Hobart;A.J. Thompson

  • Cerebellar contributions to working memory.

    A. L. Hayter;D. W. Langdon;Narender Ramnani

  • Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome.

    D W Langdon;A J Thompson

  • The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population

    Benedetta Goretti;Claudia Niccolai;Bahia Hakiki;Andrea Sturchio

  • Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis

    J A Freeman;J C Hobart;D W Langdon;A J Thompson

  • Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

    G C Ebers;A Traboulsee;D Li;D Langdon

  • High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial:

    Philipp Zimmer;Wilhelm Bloch;Alexander Schenk;Max Oberste

  • Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.

    Peter Rieckmann;Diego Centonze;Irina Elovaara

  • Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life

    J Campbell;W Rashid;M Cercignani;D Langdon

  • The Cognition and Behaviour of Children with Cochlear Implants, Children with Hearing Aids and Their Hearing Peers: A Comparison

    Sonya Khan;Lindsey Edwards;Dawn Langdon

Frequent Co-Authors

Alan J. Thompson
Alan J. Thompson University College London
Anthony T. Reder
Anthony T. Reder University of Chicago
George C. Ebers
George C. Ebers University of Oxford
Douglas S. Goodin
Douglas S. Goodin University of California, San Francisco
Ralph H.B. Benedict
Ralph H.B. Benedict University at Buffalo, State University of New York
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Gary Cutter
Gary Cutter University of Alabama at Birmingham
Wilhelm Bloch
Wilhelm Bloch German Sport University Cologne
Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying neuroscience, there are a variety of pathways to consider. Many students opt for accelerated online programs that allow for faster completion of a degree, offering convenience and flexibility—especially for those balancing work or family commitments.

Exploring the best bachelor degrees to get can help guide your career decisions, as some majors tend to lead to higher salaries and more job security. Neuroscience often overlaps with fields featured among the most lucrative college degrees, including biochemistry, computer science, and engineering.

Cost is also a crucial consideration when choosing your path. Many online colleges that accept financial aid can make earning your degree more affordable, reducing the financial burden as you work toward your goals.

Consider these factors as you weigh your options for an online neuroscience degree or related career pathways.

Best Scientists Citing Dawn Langdon

Trending Scientists

Recently Published Articles